An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Provided herein are novel aryl hydrocarbon receptor (AHR) agonist compounds, pharmaceutical compositions, use of such compounds in treating immune-mediated diseases, in particular psoriasis and atopic dermatitis, and processes for preparing such compounds.
Jin Z., Li G., He D., Chen J., Zhang Y., Li M., Yao H.. An overview of small-molecule agents for the treatment of psoriasis. Bioorg. Med. Chem. 2025;119:118067. doi: 10.1016/j.bmc.2025.118067.
-
DOI
-
PubMed
Abdel-Mageed H. M.. Atopic dermatitis: a comprehensive updated review of this intriguing disease with futuristic insights. Inflammopharmacology. 2025;33:1161–1187. doi: 10.1007/s10787-025-01642-z.
-
DOI
-
PMC
-
PubMed
Yang J., Qiao P., Wang G., Dang E.. The role of aryl hydrocarbon receptor in skin homeostasis: Implications for therapeutic strategies in skin disorders. Cell Biochem. Funct. 2025;43:e70047. doi: 10.1002/cbf.70047.
-
DOI
-
PubMed
Hawkes J. E., Al-Saedy M., Bouche N., Al-Saedy S., Drew D. T., Song E. J.. The psoriasis treatment pipeline: An overview and update. Dermatol. Clin. 2024;42:365–375. doi: 10.1016/j.det.2024.02.006.
-
DOI
-
PubMed
Sabnis R. W.. Novel aryl hydrocarbon receptor agonists for treating psoriasis and atopic dermatitis. ACS Med. Chem. Lett. 2024;15:2095–2096. doi: 10.1021/acsmedchemlett.4c00537.
-
DOI
-
PMC
-
PubMed